Hypera SA (HYPMY)
4.948
-0.10
(-2.03%)
USD |
OTCM |
Sep 27, 16:00
Hypera Profit Margin (Quarterly): 22.51% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 22.51% |
March 31, 2024 | 21.47% |
December 31, 2023 | 16.63% |
September 30, 2023 | 23.35% |
June 30, 2023 | 22.55% |
March 31, 2023 | 19.93% |
December 31, 2022 | 20.17% |
September 30, 2022 | 22.86% |
June 30, 2022 | 24.04% |
March 31, 2022 | 23.28% |
December 31, 2021 | 21.67% |
September 30, 2021 | 12.35% |
June 30, 2021 | 31.23% |
March 31, 2021 | 26.08% |
December 31, 2020 | 27.75% |
September 30, 2020 | 31.75% |
June 30, 2020 | 37.74% |
March 31, 2020 | 29.23% |
December 31, 2019 | 25.71% |
September 30, 2019 | 26.47% |
June 30, 2019 | 34.61% |
March 31, 2019 | 83.73% |
December 31, 2018 | 33.40% |
September 30, 2018 | 25.53% |
June 30, 2018 | 30.19% |
Date | Value |
---|---|
March 31, 2018 | 32.31% |
December 31, 2017 | 44.90% |
September 30, 2017 | 18.93% |
June 30, 2017 | 22.55% |
March 31, 2017 | 20.79% |
December 31, 2016 | -26.74% |
September 30, 2016 | 24.97% |
June 30, 2016 | 21.86% |
March 31, 2016 | |
December 31, 2015 | 37.42% |
September 30, 2015 | 10.21% |
June 30, 2015 | 15.30% |
March 31, 2015 | 12.29% |
December 31, 2014 | -11.70% |
September 30, 2014 | 10.00% |
June 30, 2014 | 10.79% |
March 31, 2014 | 8.52% |
December 31, 2013 | 4.91% |
September 30, 2013 | 7.21% |
June 30, 2013 | 1.81% |
March 31, 2013 | 10.67% |
December 31, 2012 | 12.14% |
September 30, 2012 | 6.89% |
June 30, 2012 | -3.13% |
March 31, 2012 | 4.55% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
12.35%
Minimum
Sep 2021
37.74%
Maximum
Jun 2020
24.34%
Average
23.32%
Median
Profit Margin (Quarterly) Benchmarks
Raia Drogasil SA | 3.37% |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -3.67K% |
IGC Pharma Inc | -874.3% |
NovaBay Pharmaceuticals Inc | -66.04% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 14.78% |
Return on Assets | 6.92% |
Return on Invested Capital | 7.88% |
Gross Profit Margin (Quarterly) | 60.92% |
Operating Margin (Quarterly) | 31.49% |
Return on Net Operating Assets | 8.36% |